| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.0047 | 0.9 |
| mRNA | dacarbazine | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.0053 | 0.9 |